newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics Added to the NASDAQ Biotechnology Index

LONDON, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company has been added to the NASDAQ Bio